IPRIPR2025-01531Final Written Decision
Apotex Inc.v.Ipsen Biopharm Ltd. et al.
IPR challenge of US 11344552.
Type
IPR
Filed
Sep 12, 2025
Instituted
Mar 3, 2026
Decided
Aug 13, 2026
Patent
Application
15809815
Inventor
Eliel Bayever et al
Granted
May 31, 2022
01
Timeline
3 milestones
2025-09-12Petition filed
2026-03-03Institution
2026-08-13Terminated
02
Parties & counsel
Petitioner
Apotex Inc.
Counsel
Molenda, Johnet al
Patent Owner
Ipsen Biopharm Ltd. et al.
Counsel
Glass, Jameset al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →